GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,964,000 | +119.3% | 249,107 | +2.9% | 0.03% | +133.3% |
| Q2 2022 | $7,736,000 | -17.3% | 242,142 | -9.5% | 0.01% | 0.0% |
| Q1 2022 | $9,349,000 | +97.9% | 267,482 | +65.8% | 0.01% | +100.0% |
| Q4 2021 | $4,723,000 | +79.7% | 161,346 | +56.4% | 0.01% | +50.0% |
| Q3 2021 | $2,628,000 | -12.0% | 103,138 | +20.9% | 0.00% | 0.0% |
| Q2 2021 | $2,987,000 | +45.8% | 85,305 | +69.7% | 0.00% | +33.3% |
| Q1 2021 | $2,048,000 | -44.0% | 50,265 | -40.4% | 0.00% | 0.0% |
| Q4 2020 | $3,656,000 | -22.2% | 84,392 | +2.4% | 0.00% | -62.5% |
| Q3 2020 | $4,698,000 | +38.3% | 82,421 | +53.2% | 0.01% | +33.3% |
| Q2 2020 | $3,397,000 | +76.9% | 53,802 | +60.9% | 0.01% | +50.0% |
| Q1 2020 | $1,920,000 | -22.9% | 33,442 | +6.8% | 0.00% | 0.0% |
| Q4 2019 | $2,490,000 | +61.3% | 31,327 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $1,544,000 | -2.0% | 31,327 | +4.5% | 0.00% | 0.0% |
| Q2 2019 | $1,576,000 | +8.3% | 29,967 | +9.0% | 0.00% | 0.0% |
| Q1 2019 | $1,455,000 | – | 27,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |